These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8573967)

  • 1. Compatibility of haloperidol and diphenhydramine in a hypodermic syringe.
    Ukhun IA
    Ann Pharmacother; 1995 Nov; 29(11):1168-9. PubMed ID: 8573967
    [No Abstract]   [Full Text] [Related]  

  • 2. Visual compatibility of neuroleptics with anticholinergics or antihistamines in polyethylene syringes.
    Gibler B; Kim MS; Raleigh F
    Am J Hosp Pharm; 1994 Nov; 51(21):2709-10. PubMed ID: 7856588
    [No Abstract]   [Full Text] [Related]  

  • 3. Visual compatibility of haloperidol lactate with injectable solutions.
    Fraser GL; Riker RR
    Am J Hosp Pharm; 1994 Apr; 51(7):905-6. PubMed ID: 8017441
    [No Abstract]   [Full Text] [Related]  

  • 4. Compatibility of haloperidol lactate with benztropine mesylate.
    Jackson CW; Cunningham K
    Am J Hosp Pharm; 1994 Dec; 51(23):2962-3. PubMed ID: 7879808
    [No Abstract]   [Full Text] [Related]  

  • 5. Compatibility of cyclizine lactate and haloperidol lactate.
    Fawcett JP; Woods DJ; Munasiri B; Becket G
    Am J Hosp Pharm; 1994 Sep; 51(18):2292. PubMed ID: 7801994
    [No Abstract]   [Full Text] [Related]  

  • 6. Compatibility of hydromorphone hydrochloride with haloperidol lactate and ketorolac tromethamine.
    Huang E; Anderson RP
    Am J Hosp Pharm; 1994 Dec; 51(23):2963. PubMed ID: 7533480
    [No Abstract]   [Full Text] [Related]  

  • 7. Visual compatibility of haloperidol lactate with 0.9% sodium chloride injection or injectable critical-care drugs during simulated Y-site injection.
    Outman WR; Monolakis J
    Am J Hosp Pharm; 1991 Jul; 48(7):1539-41. PubMed ID: 1882889
    [No Abstract]   [Full Text] [Related]  

  • 8. Visual compatibility and particle counter evaluations of syringes of intramuscular psychotropic coadministered solutions.
    Djerroud L; Leclair G; Sullivan T; Dagenais-Beaulé V
    Eur J Hosp Pharm; 2023 Mar; 30(e1):e97-e100. PubMed ID: 36002244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incompatibility of ketorolac tromethamine with haloperidol lactate and thiethylperazine maleate.
    Mendenhall A; Hoyt DB
    Am J Hosp Pharm; 1994 Dec; 51(23):2964. PubMed ID: 7879809
    [No Abstract]   [Full Text] [Related]  

  • 10. Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel.
    Dahal A; Neupane R; Boddu SH; Renukuntla J; Khupse R; Dudley R
    Int J Pharm Compd; 2020; 24(2):168-175. PubMed ID: 32196480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment: haloperidol and diphenhydramine compatibility.
    Raleigh FR; Gibler BS
    Ann Pharmacother; 1996 May; 30(5):549. PubMed ID: 8740347
    [No Abstract]   [Full Text] [Related]  

  • 12. Compatibility of dexamethasone sodium phosphate with hydromorphone hydrochloride or diphenhydramine hydrochloride.
    Walker SE; DeAngelis C; Iazzetta J; Eppel JG
    Am J Hosp Pharm; 1991 Oct; 48(10):2161-6. PubMed ID: 1723578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compounding nausea aid.
    Francom M
    Am Pharm; 1991 Jul; NS31(7):7. PubMed ID: 1951035
    [No Abstract]   [Full Text] [Related]  

  • 14. Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes.
    Anderson CR; Halford Z; MacKay M
    Int J Pharm Compd; 2015; 19(4):344-7. PubMed ID: 26625573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of tramadol and haloperidol for continuous subcutaneous infusion at home.
    Negro S; Martín A; Azuara ML; Sánchez Y; Barcia E
    J Pain Symptom Manage; 2005 Aug; 30(2):192-9. PubMed ID: 16125035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug combinations in syringe drivers: the compatibility and stability of diamorphine with cyclizine and haloperidol.
    Grassby PF; Hutchings L
    Palliat Med; 1997 May; 11(3):217-24. PubMed ID: 9205655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution-mediated phase transformation of salts during dissolution: investigation using haloperidol as a model drug.
    Greco K; Mcnamara DP; Bogner R
    J Pharm Sci; 2011 Jul; 100(7):2755-68. PubMed ID: 21328581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavior of haloperidol and various phenothiazines on several alkyl bonded phases.
    Beljean M; Siouffi AM
    J Chromatogr Sci; 2001 Jun; 39(6):229-34. PubMed ID: 11396686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chirality of reduced haloperidol in humans.
    Eyles DW; McGrath JJ; Stedman TJ; Pond SM
    Eur Neuropsychopharmacol; 1998 May; 8(2):127-9. PubMed ID: 9619691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability studies of binary mixtures of haloperidol and/or midazolam with other drugs for parenteral administration.
    Gómez MA; Arenas VJ; Sanjuán MM; Hernández MJ; Almenar CB; Torres VJ
    J Palliat Med; 2007 Dec; 10(6):1306-11. PubMed ID: 18095809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.